Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Switch Symbol:
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
10.59
↓ 90% below average
Average (9y)
108.17
Historical baseline
Range
High:341.63
Low:10.59
CAGR
-24.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 10.59 | -49.7% |
| 2023 | 21.04 | +55.7% |
| 2022 | 13.51 | -86.9% |
| 2021 | 103.45 | -69.7% |
| 2020 | 341.63 | +289.8% |
| 2019 | 87.63 | +7.5% |
| 2018 | 81.55 | -40.6% |
| 2017 | 137.35 | -12.0% |
| 2016 | 156.00 | +21.0% |
| 2015 | 128.97 | - |